Davis, CA, United States of America

Chong-Xian Pan

This inventor holds 10 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: University of California, The United States Government as Represented by the Department of Veterans Affairs, Lawrence Livermore National Security, LLC. Active years: 2015-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chong-Xian Pan. Retrieved from https://idiyas.com/inventor/chong-xian-pan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Davis, CA (US) (2015 - 2022)
  • Sacramento, CA (US) (2017 - 2022)

Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Chong-Xian Pan

Introduction

Chong-Xian Pan is an accomplished inventor based in Davis, CA, with an impressive portfolio of ten patents to his name. His work primarily focuses on innovative methods that enhance cancer treatment protocols, showcasing his dedication to advancing medical science and improving patient outcomes.

Latest Patents

Among his most notable inventions are the following:

1. **Methods for cytotoxic chemotherapy-based predictive assays** - This invention encompasses methods, systems, and kits designed to determine the therapeutic effectiveness or toxicity of cancer-treating compounds that bind to DNA. It provides physicians with a diagnostic tool to categorize cancer patients into distinct groups based on their likelihood of responding positively to specific treatments after administering a microdose of therapeutic composition.

2. **Methods of improving cancer chemotherapy** - This patent outlines methods and compositions aimed at prolonging survival and inhibiting tumor growth in cancer patients undergoing chemotherapy. By incorporating an inhibitor of soluble epoxide hydrolase (sEHi) and a non-steroidal anti-inflammatory drug (NSAID), the methods seek to decrease toxicity and adverse side effects commonly associated with chemotherapeutic regimens.

Career Highlights

Chong-Xian Pan has significantly impacted the field of cancer research through his tenure at prominent institutions. Notably, he has contributed to the University of California and served in the U.S. Government, particularly represented by the Department of Veterans Affairs. His work has placed him at the forefront of cancer treatment innovations, leading to notable advancements in therapeutic methods.

Collaborations

Throughout his career, Pan has collaborated with esteemed professionals, including Hongyong Zhang and Kit S. Lam. These partnerships have not only enhanced his research capabilities but have also fostered a collaborative environment conducive to innovation in cancer therapies.

Conclusion

Chong-Xian Pan exemplifies the spirit of innovation in the medical field, with his work having the potential to transform cancer treatment practices. His numerous patents and collaborations highlight a commitment to improving patient care and pushing the boundaries of medical science. As he continues his work, the impact of his inventions will likely resonate within both the medical community and the lives of cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…